about
Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study.Effects of advanced carbohydrate counting in patients with type 1 diabetes: a systematic review.Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.Bolus calculators.Intake of Sweets, Snacks and Soft Drinks Predicts Weight Gain in Obese Pregnant Women: Detailed Analysis of the Results of a Randomised Controlled Trial.Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.Evaluation of pharmacokinetic model designs for subcutaneous infusion of insulin aspart.Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial.Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.An Adaptive Nonlinear Basal-Bolus Calculator for Patients With Type 1 Diabetes.Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia.Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers.Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.Intake of carbohydrates during pregnancy in obese women is associated with fat mass in the newborn offspring.Long-Term Adherence to Automated Bolus Calculators.International Consensus on Use of Continuous Glucose Monitoring.The effect of peer support in adults with insulin pump-treated type 1 diabetes: a pilot study of a flexible and participatory intervention.The Treatment of Obese Pregnant Women (TOP) study: a randomized controlled trial of the effect of physical activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women.Representativeness of participants in a lifestyle intervention study in obese pregnant women - the difference between study participants and non-participants.Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate counting.Physical activity during pregnancy in obese and normal-weight women as assessed by pedometer.Newborn regional body composition is influenced by maternal obesity, gestational weight gain and the birthweight standard score.Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.Effects of advanced carbohydrate counting guided by an automated bolus calculator in Type 1 diabetes mellitus (StenoABC): a 12-month, randomized clinical trial.Glucose tolerance in obese pregnant women determines newborn fat mass.Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study.Effects of alcohol on plasma glucose and prevention of alcohol-induced hypoglycemia in type 1 diabetes-A systematic review with GRADE.A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark. Danish Study Group of Diabetes in Childhood.Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study.Bihormonal control of blood glucose in people with type 1 diabetesThe contribution of glucagon in an Artificial Pancreas for people with type 1 diabetesSkin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional StudyRetinal function in relation to improved glycaemic control in type 1 diabetesSensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial
P50
Q30419517-ED71B5F0-4032-413F-92F8-3AB39A2011CCQ35127131-F81EF762-9821-404B-84E0-53B4780F077EQ35627208-55EE9895-B745-49AB-90AB-B9CBC127ACDFQ35682686-E0D0F6C2-123B-4062-A949-CA2FA9812526Q35698366-20E1D5C8-33BE-418C-A527-5DD428843C14Q36159086-C9FFAF97-27BC-4543-B843-7B4D0D1039E2Q36244234-5A77C1CE-A917-4A80-AD68-60F58F16ADE6Q38297682-A794B406-9F92-4F28-A4F7-339AD9BD382BQ38498029-E0E89E64-8214-4F38-B886-46DEDE024B38Q38613015-94864E86-12E1-4B1D-B9B2-B0090A9BB6C2Q38707076-76192556-9327-42CF-ABDC-7FCA4F4730E3Q38874435-D888A159-267B-4853-9C0F-19B780F5FDB3Q39164012-408D2181-1DC2-4920-8966-8C5CFAFE069FQ39198937-394AEA18-730D-49CC-9C18-2B6CDE626702Q39404956-C63AEB36-499E-4477-9BF6-3B518F01E622Q39667350-791820BD-0506-476D-85A5-74723950B416Q40378270-6B252614-9737-4A05-81B5-693C47D7DF37Q40805930-8B51D260-2DFE-4CC7-B5EE-41808B1F0967Q41129241-FE2D0B59-1607-4D10-A44F-A39DD258B5BDQ43143816-75A94EB3-77F4-4919-8DCE-1BCF0C0380F8Q45073594-613AB7B5-16C4-4165-AAF7-B483DB099957Q46086150-77F410AE-8DDF-41EB-BB83-CB6E0648F9A6Q46592142-C85F55B6-C247-464F-8A12-BC892CAF709FQ46733159-F8AFBCB4-E0BC-4594-BC08-46A755F97EC4Q47317448-6A53D3B4-AF97-45E4-B946-71CE4F8D7996Q47426370-DF865AD3-6C1A-4339-8C99-00E80FB5376AQ47580020-7B7F9CD6-9C0A-4067-89FC-2CE497798437Q47773370-9F66BB57-C93F-4F72-BAF6-D209BB3580D1Q47908543-7D8D1F3C-C2CA-4AC3-B5A5-0BF3FBC3DDC9Q48044809-7A3B07D7-8906-4B7F-99ED-9F314B70DEE7Q48261665-747AC8B7-D746-453A-993A-B6BCE855862BQ48308282-1366B254-0BDC-4781-ABC3-A0A7BDF6C3C0Q50558674-BA6F696D-FB18-4CC0-B2AB-38457490D9DCQ51291232-F0064D4D-9D56-48A0-B5A0-43C7D0C0647AQ51352686-655440E4-94A5-4EAE-B2C2-A2BE90BD5A7AQ53541367-C2E0450B-DA1F-4E1F-8557-949A5556ED91Q53541417-B51F2B35-C256-4565-B7DD-686A79DC298DQ57177952-7F798E98-C766-41D9-BA0A-224A42BF4FD4Q58167941-0E5829CE-9180-45F4-85EC-53AC856C6162Q58886172-9AA9BA7E-49D0-4B3B-9DE0-2A6C8434EF24
P50
description
forsker
@da
researcher ORCID ID = 0000-0003-1620-8271
@en
wetenschapper
@nl
name
Kirsten Nørgaard
@ast
Kirsten Nørgaard
@da
Kirsten Nørgaard
@de
Kirsten Nørgaard
@en
Kirsten Nørgaard
@es
Kirsten Nørgaard
@fo
Kirsten Nørgaard
@fr
Kirsten Nørgaard
@is
Kirsten Nørgaard
@kl
Kirsten Nørgaard
@nb
type
label
Kirsten Nørgaard
@ast
Kirsten Nørgaard
@da
Kirsten Nørgaard
@de
Kirsten Nørgaard
@en
Kirsten Nørgaard
@es
Kirsten Nørgaard
@fo
Kirsten Nørgaard
@fr
Kirsten Nørgaard
@is
Kirsten Nørgaard
@kl
Kirsten Nørgaard
@nb
altLabel
Kirsten Norgaard
@da
Kirsten Norgaard
@de
Kirsten Norgaard
@en
Nørgaard, Kirsten
@da
Nørgaard, Kirsten
@de
Nørgaard, Kirsten
@en
prefLabel
Kirsten Nørgaard
@ast
Kirsten Nørgaard
@da
Kirsten Nørgaard
@de
Kirsten Nørgaard
@en
Kirsten Nørgaard
@es
Kirsten Nørgaard
@fo
Kirsten Nørgaard
@fr
Kirsten Nørgaard
@is
Kirsten Nørgaard
@kl
Kirsten Nørgaard
@nb
P106
P1153
7004136918
P21
P2456
P31
P496
0000-0003-1620-8271